Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. - Wikidata - wikimedia - TriplyDB

Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.

Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.

http://www.wikidata.org/entity/Q33954674

about

Update in asthma 2009 The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity Skin exposure and asthma: is there a connection?Recent insights into atopic dermatitis and implications for management of infectious complications.Aligning mouse models of asthma to human endotypes of disease.Interleukin-17 regulation: an attractive therapeutic approach for asthma Anisakis pegreffii-induced airway hyperresponsiveness is mediated by gamma interferon in the absence of interleukin-4 receptor alpha responsiveness.Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism.Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma.Early immunological response to German cockroach frass exposure induces a Th2/Th17 environment.The endogenous Th17 response in NO2-promoted allergic airway disease is dispensable for airway hyperresponsiveness and distinct from Th17 adoptive transfer.Inflammasome Activity in Non-Microbial Lung Inflammation.Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.IL-17A expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization.Th2 Cytokines and Atopic Dermatitis.Inefficient lymph node sensitization during respiratory viral infection promotes IL-17-mediated lung pathology.Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica.Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis.Blockage of Eosinopoiesis by IL-17A Is Prevented by Cytokine and Lipid Mediators of Allergic Inflammation.Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma.Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis.The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis Interleukin-13 signaling and its role in asthma Immunotherapy in asthma.The role of inflammasome-derived IL-1 in driving IL-17 responses.Molecular biology of atopic dermatitis.Allergic mechanisms in eosinophilic esophagitis.Predicting risk for childhood asthma by pre-pregnancy, perinatal, and postnatal factors.IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion.Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity.Interplay between barrier epithelial cells and dendritic cells in allergic sensitization through the lung and the skin.Phenotypic analysis of perennial airborne allergen-specific CD4+ T cells in atopic and non-atopic individuals.The Role of TSLP in IL-13-induced atopic march.Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses.EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis.

P2860

Q24599763-C32D8449-C950-4F0E-BF25-C9B860A474E6 Q26823953-2F2EA37B-302B-45C6-9208-137DEAFB8F9B Q28387629-FCBA36B3-2B17-49B7-9B0E-7DDAFDF4B851 Q28395994-53CB46F6-03D1-4614-9464-F9B6E7CE1DA9 Q33621496-7C97DE0C-ABF3-4861-B60D-8C92DD45CF53 Q33934140-21A3A34F-19A2-4FD5-830A-305304DD2A30 Q33951731-D133FA43-2F9C-4F4F-8E72-357DE19F24B2 Q34119421-7C6956BE-5A0A-4B09-8E7D-574154755F53 Q34357756-151988F7-3936-4C05-A43D-AB6D52874F94 Q34427654-B8C0365E-A681-48D1-B719-53F53F1BBAD4 Q34527154-9E6309CA-6346-4045-8F18-2FA28502D4D4 Q34556081-8C36559D-E440-4C91-A3A5-1A09F3CF4DC8 Q34769429-A3CF57D2-36E0-4524-88B3-2F7397E8AE0E Q34999285-64CC236C-5BBF-43C3-8E8F-8CD41DD860C7 Q35020676-6D19F9DB-E410-4399-8515-8D76229E881E Q35065037-70A6F35E-CC63-4B8B-A193-E6E634129A21 Q35149947-EC50C31E-6506-43F9-87B4-1E200AEAB663 Q35294155-39D624D4-BFCE-47EB-9312-C5DEA5635F6E Q35563217-2469DD34-2388-47D6-B23C-EE68578EEE8C Q35665393-90F3330F-584D-4C31-B572-4AFC4F815C83 Q35746514-6259675B-F575-4283-B47B-27405A078133 Q35823899-1300FF38-9314-4372-A7B3-E3473A38CB80 Q35889245-3483C679-FA2C-4989-A677-F292F54B1214 Q35894790-16C791A8-E28E-44C1-B5C3-2D6D28D8034F Q36256954-80ED3D79-A9DA-4ABE-B6D6-AD21664BE0BF Q36272421-907BBDD8-D4D3-42DB-AA62-7FE0CA91A062 Q36814164-AAE508D5-3B5C-4C38-8430-4A5ED0DB5EE9 Q36834591-6C2FDB33-8744-4EB9-82BE-F1C7A1E1C4FA Q37793242-19D61C08-D9B7-4875-B93E-B5F744C29C34 Q38070133-37502737-77F0-45A1-B089-9F7EF5DAE12C Q38203185-88F45614-0A65-440C-BA69-EB045C50F50F Q38210618-FA559B88-A77B-4456-BDCB-23037005303B Q38415789-0C2079D1-D253-41FF-A006-2108DADB9558 Q38498941-D21BD1CB-2EC3-4B5F-B735-561E4FE9CCD4 Q38707910-7958CF83-3337-4F8D-8484-FD0EE42CE26B Q39402927-C6600000-2611-4C1D-A060-DEF14DC1444B Q39512639-CA7086FA-3C94-438A-8224-1EC4167CF68B Q40179211-92E5F39E-D039-4127-9843-A8BFB4172D15 Q40726914-0E23BF08-B195-4749-9591-805A66DC6FA1 Q41845806-F6996DF3-6E66-4B35-91B4-3806A3A814F9

P2860

Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.

http://www.wikidata.org/entity/Q33954674

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Exaggerated IL-17 response to ...... the absence of IL-4 and IL-13.

@ast

Exaggerated IL-17 response to ...... the absence of IL-4 and IL-13.

@en

type

label

Exaggerated IL-17 response to ...... the absence of IL-4 and IL-13.

@ast

Exaggerated IL-17 response to ...... the absence of IL-4 and IL-13.

@en

prefLabel

Exaggerated IL-17 response to ...... the absence of IL-4 and IL-13.

@ast

Exaggerated IL-17 response to ...... the absence of IL-4 and IL-13.

@en

P1433

Q33954674-2AA1C7C7-9C2D-4053-8E24-44D9456B8573

P1476

Q33954674-E9896E41-ABC3-4E05-B51E-AD37F834089B

P2093

Q33954674-197ADDF2-45D0-45D4-BEF2-902EB30F0BBF

Q33954674-1A83C875-5EF2-4774-9230-2E110D8238E1

Q33954674-369825F9-4D27-45EC-8C9E-430031998CCE

Q33954674-40A055FB-5869-4F01-BFBF-2E54E07E72E9

Q33954674-4157E988-790D-493A-902F-A1789E52202E

Q33954674-5E094698-1D5E-46EB-A823-1E3E4C9B9419

Q33954674-7A882650-B6AD-449F-9E23-CF2B4BA936F7

Q33954674-82320545-1D92-4DB1-864E-164039D89202

Q33954674-BE73C10A-A638-4A7D-834B-2A305F2FC52F

Q33954674-C54C9525-C504-43C2-BE5F-79CC5BC0E712

P2860

Q33954674-052D7190-0939-48AB-9DCD-50257E9D08A1

Q33954674-090010FA-4C99-4F6B-8490-E74D605727C6

Q33954674-0E9581D9-1195-4BBA-99B8-B0963531C9BB

Q33954674-1213EF46-B4CE-4AC0-8977-0B27BC648588

Q33954674-2086FDD4-8A81-45D6-8719-D4CA3857FBC6

Q33954674-2140A630-32A8-4B24-B725-97CF6F6A6463

Q33954674-2BED3F3E-B304-4D7E-84A3-2B7315621194

Q33954674-35ADAC87-914D-41FC-A11E-252BAB8E07E7

Q33954674-3785BE0D-4640-4214-8EE1-46300BA2CC2F

Q33954674-3BFA8400-124E-43F8-9BF2-E54BB3041DC1

P304

Q33954674-0E0918A3-5B33-44D4-9C0F-871F8DCCE7D3

P31

Q33954674-5E48E79C-BA8E-43D1-A711-B484AF9D1637

P356

Q33954674-F9AB8BEB-5673-4BA4-9D79-511D8C34565D

P407

Q33954674-489DC870-C423-4434-A220-C05E308FBDD3

P433

Q33954674-F7A61AE9-FBE4-4ACB-B583-BFD186E83D48

P478

Q33954674-C5B6CEDC-A7DA-4D25-9250-1C8A1840C4D0

P50

Q33954674-F7EDCE3F-AED2-4895-A495-8ED374ED5FD0

P577

Q33954674-A44927B4-638C-4B5F-BC46-A31ED42521DF

P5875

Q33954674-C78DD5B4-8A8E-497A-BCCF-0E4662C78CC9

P698

Q33954674-396A638E-69B2-4FE9-A534-5ECE9D28785B

P932

Q33954674-90A765EB-980F-4E37-BF3C-A4B602AC8070

P356

J.JACI.2009.07.040

P1433

The Journal of Allergy and Clinical Immunology

P1476

Exaggerated IL-17 response to ...... the absence of IL-4 and IL-13.

@en

P2093

Andrew MacGinnitie

http://www.w3.org/2001/XMLSchema#string

Dale T Umetsu

http://www.w3.org/2001/XMLSchema#string

Eva-Jasmin Freyschmidt

http://www.w3.org/2001/XMLSchema#string

Hans C Oettgen

http://www.w3.org/2001/XMLSchema#string

Hye Young Kim

http://www.w3.org/2001/XMLSchema#string

Juhan Yoon

http://www.w3.org/2001/XMLSchema#string

Michiko K Oyoshi

http://www.w3.org/2001/XMLSchema#string

Paul Bryce

http://www.w3.org/2001/XMLSchema#string

Raif S Geha

http://www.w3.org/2001/XMLSchema#string

Rui He

http://www.w3.org/2001/XMLSchema#string

P2860

IL-17 cytokine family

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.

Cytokines and chemoattractants in allergic inflammation.

CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation

Atopic dermatitis and asthma: parallels in the evolution of treatment.

P304

761-70.e1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2009.07.040

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Andrew N. J. McKenzie

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26881106

http://www.w3.org/2001/XMLSchema#string

P698

19815118

http://www.w3.org/2001/XMLSchema#string

P932

2895457

http://www.w3.org/2001/XMLSchema#string